Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT00125203 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis
Sialorrhea

Interventions

DRUG: Botulinum toxin type B (Myobloc)
PROCEDURE: Injection of salivary glands

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]
[object Object]
[object Object]